Unlocking Digestive Health: Linaclotide Acetate (CAS 851199-59-2) for IBS-C & CIC Management

Discover Linaclotide Acetate, a leading peptide API proven to revolutionize the management of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation.

Get a Quote & Sample

Key Advantages of Choosing Linaclotide

Superior Efficacy in GI Disorders

Linaclotide offers superior efficacy in managing symptoms associated with IBS-C treatment and Chronic Idiopathic Constipation, improving patient quality of life.

Advanced Pharmacological Mechanism

Its unique action as a guanylate cyclase C agonist ensures a targeted approach, distinguishing it from conventional therapies and providing lasting relief.

Reliable & Safe Profile

With a well-established safety profile and minimal systemic absorption, Linaclotide is a trusted choice for long-term management of chronic gastrointestinal conditions.

Key Applications

Irritable Bowel Syndrome with Constipation (IBS-C)

Linaclotide is a cornerstone in the treatment of Irritable Bowel Syndrome with Constipation (IBS-C), significantly improving both abdominal pain and bowel frequency.

Chronic Idiopathic Constipation (CIC)

For patients suffering from Chronic Idiopathic Constipation (CIC), Linaclotide provides effective relief by enhancing intestinal motility and fluid secretion.

Beyond Common GI Disorders

Emerging research shows potential for Linaclotide in other challenging conditions like gastroparesis and certain manifestations of ulcerative colitis.

Cosmetic & Research Applications

Beyond pharmaceutical uses, its high-purity cosmetic grade linaclotide peptides make it valuable for advanced research and specialized cosmetic formulations.